SCHEMBL30168136

SCHEMBL30168136

Cc1cc([N+](=O)[O-])ccc1N1CCCC1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.55
CASP6 P55212 2/20 0.55
POLB P06746 1/20 0.55
APEX1 P27695 1/20 0.55
CTDSP1 Q9GZU7 1/20 0.55
KDM4E B2RXH2 2/20 0.52
GAA P10253 2/20 0.52
HTT P42858 2/20 0.52
AKR1C3 P42330 1/20 0.49
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP3A4 P08684 2/20 0.49
TSHR P16473 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NR1H4 Q96RI1 1/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
RAB9A P51151 1/20 0.45
CASP1 P29466 1/20 0.44
CASP3 P42574 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24105032 1.00 TDP1 (0.55) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL85584 0.96 TDP1 (0.53) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL5415229 0.94 TDP1 (0.52) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL17979815 0.89 TDP1 (0.51) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL3675118 0.84 ALDH1A1 (0.48) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL8325167 0.83 CASP6 (0.55) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL85570 0.83 POLB (0.55) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL78723 0.83 ALDH1A1 (0.62) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL6140258 0.82 TDP1 (0.69) TDP1CASP6POLBAPEX1CTDSP1
SCHEMBL8338200 0.82 AKR1C3 (0.46) TDP1CASP6POLBAPEX1CTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042408-A1 METHODS OF TREATING CANCER SCHRÖDINGER, INC. (US) 2025-02-27 WO disclosed
CN-115667264-A Novel imidazo-pyrazine derivatives 豪夫迈·罗氏有限公司 2023-01-31 CN disclosed